HK1130698A1 - Methods and compositions comprising supramolecular constructs - Google Patents

Methods and compositions comprising supramolecular constructs

Info

Publication number
HK1130698A1
HK1130698A1 HK09109498.9A HK09109498A HK1130698A1 HK 1130698 A1 HK1130698 A1 HK 1130698A1 HK 09109498 A HK09109498 A HK 09109498A HK 1130698 A1 HK1130698 A1 HK 1130698A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
supramolecular constructs
supramolecular
constructs
Prior art date
Application number
HK09109498.9A
Other languages
English (en)
Inventor
Yves Claude Nicolau
Ruth Greferath
David Hickman
Original Assignee
Ac Immune Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/783,975 external-priority patent/US20040242845A1/en
Priority claimed from US10/958,211 external-priority patent/US8663650B2/en
Application filed by Ac Immune Sa filed Critical Ac Immune Sa
Publication of HK1130698A1 publication Critical patent/HK1130698A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK09109498.9A 2004-02-20 2009-10-14 Methods and compositions comprising supramolecular constructs HK1130698A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/783,975 US20040242845A1 (en) 2003-02-21 2004-02-20 Methods and compositions comprising supramolecular antigenic constructs and antibodies elicited against them
US10/958,211 US8663650B2 (en) 2003-02-21 2004-10-04 Methods and compositions comprising supramolecular constructs
PCT/US2005/005285 WO2005081872A2 (en) 2004-02-20 2005-02-22 Methods and compositions comprising supramolecular constructs

Publications (1)

Publication Number Publication Date
HK1130698A1 true HK1130698A1 (en) 2010-01-08

Family

ID=46395388

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09109498.9A HK1130698A1 (en) 2004-02-20 2009-10-14 Methods and compositions comprising supramolecular constructs
HK12113161.2A HK1172260A1 (en) 2004-02-20 2012-12-20 Methods and compositions comprising supramolecular constructs

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK12113161.2A HK1172260A1 (en) 2004-02-20 2012-12-20 Methods and compositions comprising supramolecular constructs

Country Status (11)

Country Link
JP (1) JP4934433B2 (de)
KR (1) KR101277004B1 (de)
CY (1) CY1116316T1 (de)
DK (1) DK2465533T3 (de)
ES (2) ES2385226T3 (de)
HK (2) HK1130698A1 (de)
HR (1) HRP20150612T1 (de)
HU (1) HUE025186T2 (de)
PT (1) PT2465533E (de)
RS (1) RS54074B1 (de)
SI (1) SI2465533T1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2408807T3 (da) * 2009-03-18 2021-08-09 Ac Immune Sa Fremgangsmåde til terapeutisk anvendelse
CN103189050B (zh) * 2010-10-26 2017-09-29 Ac免疫有限公司 包含通过疏水部分修饰的肽的基于脂质体的构建体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187335B1 (en) * 1997-12-31 2001-02-13 Orasomal Technologies, Inc. Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
AU2600499A (en) * 1998-02-13 1999-08-30 Arch Development Corporation Methods and compositions comprising the use of blocked b-amyloid peptide
ATE424431T2 (de) * 1999-12-22 2009-03-15 Nektar Therapeutics Al Corp Verfahren zur herstellung von 1- benzotriazolcarbonatestern von wasserlöslichen polymeren

Also Published As

Publication number Publication date
SI2465533T1 (sl) 2015-07-31
RS54074B1 (en) 2015-10-30
ES2385226T3 (es) 2012-07-19
HRP20150612T1 (hr) 2015-07-03
HUE025186T2 (en) 2016-02-29
KR101277004B1 (ko) 2013-06-24
ES2385226T9 (es) 2013-10-10
PT2465533E (pt) 2015-06-24
JP2007527870A (ja) 2007-10-04
CY1116316T1 (el) 2017-02-08
HK1172260A1 (en) 2013-04-19
KR20120097546A (ko) 2012-09-04
JP4934433B2 (ja) 2012-05-16
DK2465533T3 (en) 2015-04-20
ES2539262T3 (es) 2015-06-29

Similar Documents

Publication Publication Date Title
HK1209729A1 (en) Compounds, compositions and methods
AP2089A (en) Compositions and methods for combination antiviraltherapy
EP1895838A4 (de) Zusammensetzungen und verfahren
GB0422525D0 (en) Dermatological compositions and methods
IL181543A0 (en) Dendrimer based compositions and methods of using the same
GB0411940D0 (en) Methods and compositions
EP1701725A4 (de) Verfahren und zusammensetzungen
EP1968526A4 (de) Schäumende dentalzusammensetzungen und verfahren
EP1951050A4 (de) Therapeutische zusammensetzungen und verfahren
EP1778219A4 (de) Ascophyllum-zusammensetzungen und verfahren
ZA200704295B (en) Arthrospira-based compositions and uses thereof
EP1773386A4 (de) Vakzinzusammensetzungen und -verfahren
IL182126A (en) Preparations containing and used in the history of 5-phenoxyalkoxypsoralen
IL184062A0 (en) Visco-supplement composition and methods
ZA200805079B (en) Immunostimulatory compositions and methods
HK1172260A1 (en) Methods and compositions comprising supramolecular constructs
GB0501348D0 (en) Compositions and methods
GB0424051D0 (en) Compounds and compositions
EP1761244A4 (de) Zusammensetzungen auf isocyanatbasis und ihre verwendung
EP1608970A4 (de) Ccn3-zusammensetzungen und verfahren
ZA200706038B (en) Visco-supplement composition and methods
GB0428034D0 (en) Compositions and methods
EP1841406A4 (de) Verfahren und formulierungen
GB0525968D0 (en) Compositions and methods
GB0330062D0 (en) Compositions and methods

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20240222